Cargando…
Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms
OBJECTIVE: Thrombin-activatable fibrinolysis inhibitor (TAFI) reduces the breakdown of fibrin clots through its action as an indirect inhibitor of plasmin. Studies in TAFI-deficient mice have implicated a potential role for TAFI in Abdominal Aortic Aneurysm (AAA) disease. The role of TAFI inhibition...
Autores principales: | Bridge, Katherine, Revill, Charlotte, Macrae, Fraser, Bailey, Marc, Yuldasheva, Nadira, Wheatcroft, Stephen, Butlin, Roger, Foster, Richard, Scott, D. Julian, Gils, Ann, Ariёns, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417566/ https://www.ncbi.nlm.nih.gov/pubmed/28472123 http://dx.doi.org/10.1371/journal.pone.0177117 |
Ejemplares similares
-
Common FXIII and Fibrinogen Polymorphisms in Abdominal Aortic Aneurysms
por: Macrae, Fraser L., et al.
Publicado: (2014) -
Transglutaminase 2 moderates the expansion of mouse abdominal aortic aneurysms
por: Griffin, Kathryn J., et al.
Publicado: (2021) -
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021) -
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
por: Valnickova, Zuzana, et al.
Publicado: (2009) -
Alternative SET/TAFI Promoters Regulate Embryonic Stem Cell Differentiation
por: Edupuganti, Raghu Ram, et al.
Publicado: (2017)